Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genomic Analysis of wig-1 Pathways

ABSTRACT: Analysis of wig-1 pathways via suppression of Wig-1 by antisense oligonucleotides

ORGANISM(S): Mus musculus

PROVIDER: GSE29751 | GEO | 2011/06/06

SECONDARY ACCESSION(S): PRJNA140959

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Genomic Analysis of wig-1 Pathways

Project description:Analysis of wig-1 pathways via suppression of Wig-1 by antisense oligonucleotides Total RNA obtained from mouse brain subjected to antisense oligonucleotide (ASO) treatement compared to PBS (control), and negative control ASO brain treatment.

2011-06-06 | E-GEOD-29751 | biostudies-arrayexpress

RNA antisense oligonucleotide pulldown coupled with mass spectrometry (MS) to identify C1QTNF1-AS1 protein interactors

Project description:We used C1QTNF1-AS1 antisense oligonucleotide pulldown coupled with MS to identify protein interactors of lncRNA C1QTNF1-AS1 in human HCT116 cells. Five antisense oligonucleotides against C1QTNF1-AS1 and luciferase (negative control) were used for the pulldown. Three independent oligonucleotides (C1QTNF1-AS1 oligonucleotides 1, 3 and 5), efficiently retrieve C1QTNF1-AS1 and extracted proteins from these samples were compared using label-free (LFQ) Quantitative proteomics. C1QTNF1-AS1 oligonucleotides 2 and 4 were excluded from the analysis as they did not retrieve C1QTNF1-AS1.

2026-03-12 | PXD059546 | Pride

Proteomic analysis of Psmd9 knockdown in the liver

Project description:We have shown that decreasing psmd9 expression effects lipid metabolism in vivo and were interested in investigating the pathways by which psmd9 elicited these changes. To investigate these mechanisms, we performed proteomic analyses on the livers from C57 and DBA mice that had been treated with antisense oligonucleotides targeted to psmd9.

2019-03-14 | PXD010759 | Pride

RNA-seq analysis of HeLa cells treated with GapmeR antisense oligonucleotides

Project description:RNA-seq analysis of HeLa cells treated with GapmeR antisense oligonucleotides

| PRJEB25110 | ENA

Transcriptome profiling of primary human aortic Vascular Smooth Muscle cells abrogated of NEIL3 mRNA via antisense oligonucleotides targeting NEIL3 exon 4

Project description:We performed high-throughput RNA sequencing to characterize possible differences in the transcriptome of primary human aortic Vascular Smooth Muscle cells abrogated of NEIL3 mRNA via antisense oligonucleotides targeting NEIL3 exon 4, compared with control cells treated with a scramble version of the same antisense oligonucleotide

2021-03-15 | GSE140789 | GEO

Comparison of gene expression in embryos in wich Smicl has been knocked-down and in control embryos

Project description:Embryos were injected with either control or Smicl antisense morpholino oligonucleotides and harvested at Stage 10.5 for RNA analysis. Keywords: Knock-down analysis

2009-05-30 | GSE4952 | GEO

Comparison of gene expression in embryos in wich Activin B has been knocked-down and in control embryos

Project description:Embryos were injected with either control or Activin antisense morpholino oligonucleotides and harvested at Stage 10.5 for RNA analysis. Keywords: Knock-down analysis

2007-05-04 | GSE4771 | GEO

Gapmer ASO targeting

Project description:Antisense oligonucleotides gapmers with multiple targets

| PRJEB53196 | ENA

Gene expression profile of modified gapmer antisense oligonucleotides treated mouse liver

Project description:To investigate gene expression change induced by modified gapmer antisense oligonucleotides, we performed transcriptome analysis of Scarb1 ASO or PBS treated mouse livers.

2025-03-28 | GSE289964 | GEO

Canagliflozin impairs T-cell effector function via metabolic suppression in autoimmunity [Metabolic Pathways]

Project description:Canagliflozin impairs T-cell effector function via metabolic suppression in autoimmunity [Metabolic Pathways]

| PRJNA952145 | ENA